Literatura científica selecionada sobre o tema "Diseases"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Diseases".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Diseases"
Limpert, E., e P. Bartoš. "Wind-Dispersed Nomadic Diseases: Conclusions for Disease Resistance". Czech Journal of Genetics and Plant Breeding 38, No. 3-4 (1 de agosto de 2012): 150–52. http://dx.doi.org/10.17221/6256-cjgpb.
Texto completo da fonteDehuri, Priyadarshini, Debasis Gochhait, Debdatta Basu e Neelaiah Siddaraju. "Rosai-Dorfman Disease: An Imposter of Plasma Cell Rich Diseases". Annals of Pathology and Laboratory Medicine 2, n.º 12 (17 de dezembro de 2018): C178–181. http://dx.doi.org/10.21276/apalm.2102.
Texto completo da fonteBalaji, SM. "Noncommunicable diseases and dental diseases". Indian Journal of Dental Research 29, n.º 6 (2018): 699. http://dx.doi.org/10.4103/ijdr.ijdr_895_18.
Texto completo da fonteHeinz, Don J., e Steve A. Ferreira. "Diseases of sugarcane. Major diseases". Field Crops Research 19, n.º 1 (agosto de 1988): 77–78. http://dx.doi.org/10.1016/0378-4290(88)90037-8.
Texto completo da fonteMATSUMOTO, KEIZO. "Emerging infectious diseases and insensible bacillus infectious diseases. Emerging infectious diseases. Influenza virus infection diseases." Nihon Naika Gakkai Zasshi 86, n.º 11 (1997): 2033–38. http://dx.doi.org/10.2169/naika.86.2033.
Texto completo da fonteKadirovna, Muratova Saodat, Shukurova Nodira Tillayevna, Baratov Bobur e Teshayev Shoxjahon. "PREDICTIVE MODELING OF THE PROBABILITY OF DEVELOPING PERIODONTAL DISEASES IN PATIENTS WITH CARDIOVASCULAR DISEASE". European International Journal of Multidisciplinary Research and Management Studies 4, n.º 4 (1 de abril de 2024): 65–70. http://dx.doi.org/10.55640/eijmrms-04-04-10.
Texto completo da fonte&NA;. "Diseases". Inpharma Weekly &NA;, n.º 872 (janeiro de 1993): 5. http://dx.doi.org/10.2165/00128413-199308720-00007.
Texto completo da fonteKumagai, Shunichi. "7. Collagen Diseases and Allergic Diseases". Nihon Naika Gakkai Zasshi 97, n.º 12 (2008): 2991–97. http://dx.doi.org/10.2169/naika.97.2991.
Texto completo da fonteTatsumi, Koichiro. "Respiratory diseases as lifestyle-related diseases". Health Evaluation and Promotion 39, n.º 6 (2012): 821–28. http://dx.doi.org/10.7143/jhep.39.821.
Texto completo da fonteArma, Utmi, e Nadhifah Salsabila. "Peri-Implant Diseases and Gastrointestinal Diseases". Archives of Orofacial Sciences 16, Supp. 1 (22 de setembro de 2021): 1–4. http://dx.doi.org/10.21315/aos2021.16.s1.1.
Texto completo da fonteTeses / dissertações sobre o assunto "Diseases"
Pietravalle, SteÌphane. "Modelling weather/disease relationships in winter wheat diseases". Thesis, University of Reading, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.402602.
Texto completo da fonteHaslam, Bryan (Bryan Todd). "Learning diseases from data : a disease space odyssey". Thesis, Massachusetts Institute of Technology, 2017. http://hdl.handle.net/1721.1/114002.
Texto completo da fonteCataloged from PDF version of thesis.
Includes bibliographical references (pages 253-280).
Recent commitments to enhance the use of data for learning in medicine provide the opportunity to apply instruments and abstractions from computational learning theory to systematize learning in medicine. The hope is to accelerate the rate at which we incorporate knowledge and improve healthcare quality. In this thesis, we work to bring further clarity to the ways in which computational learning theory can be applied to update the collective knowledge about diseases. Researchers continually study and learn about the complex nature of the human body. They summarize this knowledge with the best possible set of diseases and how those diseases relate to each other. We draw on computational learning theory to understand and broaden this form of collective learning. This mode of collective learning is regarded as unsupervised learning, as no disease labels are initially available. In unsupervised learning, variance is typically reduced to find an optimal function to organize the data. A significant challenge that remains is how to measure variance in the definition of diseases in a comprehensive way. Variance in the definition of a disease introduces a systematic error in both basic and clinical research. If measured, it would also be possible to use computers to efficiently minimize variance, providing a great opportunity for learning by utilizing medical data. In this thesis, we demonstrate that it is possible to estimate variance in the disease taxonomy, effectively estimating an error bar for the current definitions of diseases. We do so using the history of the disease taxonomy and comparing it with a variety of external data sets that relate diseases to attributes such as symptoms, drugs and genes. We demonstrate that variance can be significant over relatively short time periods. We further present methods for updating the disease taxonomy by reducing variance based on external disease data sets. This makes it possible to automatically incorporate information contained in disease data sets into the disease taxonomy. The approach also makes it possible to use expert information encoded in the taxonomy to systematically transfer knowledge and update other biomedical data sets that are often sparse (e.g. - symptoms associated with diseases). A natural question stemming from these results is how granular does data need to be to make improvements? For instance, is patient-level data necessary to enable learning at the macro level of disease? Or are there strategies to extract information from other kinds of data to alleviate the need for very granular data. We show that detailed, patient-level data is not necessarily needed to extract detailed biological data. We do so by comparing disease relationships learned from clinical trial metadata to disease relationships learned from a detailed genetic database and show we can achieve similar results. This result shows that we can use currently available data and take advantage of computational learning to improve disease learning, which suggests a new avenue to improving patient outcomes. By reducing variance within diseases using data available today, we can quickly update the space of diseases to be more precise. Precise diseases lead to better learning in other areas of medicine and ultimately improved healthcare quality.
by Bryan Haslam.
Ph. D.
Guallar-Hoyas, Cristina. "Prospecting for markers of disease in respiratory diseases". Thesis, Loughborough University, 2013. https://dspace.lboro.ac.uk/2134/12415.
Texto completo da fonteMancini, Sabrina. "Assessment of a screening test for MMP-8 activity in the diagnosis of periodontal diseases". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape11/PQDD_0028/MQ40755.pdf.
Texto completo da fonteGu, Mei. "Mitochondrial function in Parkinson's disease and other neurodegenerative diseases". Thesis, University College London (University of London), 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.322371.
Texto completo da fonteUllah, Naseem. "Disease modules identification in heterogenous diseases with WGCNA method". Thesis, Högskolan i Skövde, Institutionen för biovetenskap, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-16692.
Texto completo da fonteGadd, Malin. "Cardiovascular diseases in immigrants in Sweden /". Stockholm : Neurotec, Center for family and community medicine, Karolinska institutet, 2006. http://diss.kib.ki.se/2006/91-7140-627-1/.
Texto completo da fonteFranco, Iborra Sandra. "Mitochondrial quality control in neurodegenerative diseases: focus on Parkinson’s disease and Huntington’s disease". Doctoral thesis, Universitat Autònoma de Barcelona, 2018. http://hdl.handle.net/10803/565668.
Texto completo da fonteIn the past years, several important advances have expanded our understanding of the pathways that lead to cell dysfunction and death in Parkinson’s disease (PD) and Huntington’s disease (HD). Both diseases are movement disorders characterized by the loss of a specific subset of neurons within the basal ganglia, dopaminergic neurons in the substantia nigra pars compacta (SNpc), in the case of PD, and medium spiny neurons in the striatum, in the case of HD,. Despite distinct clinical and pathological features, these two neurodegenerative disorders share critical underlying pathogenic mechanisms such as the presence of misfolded and/or aggregated proteins, oxidative stress and mitochondrial anomalies. Mitochondria are the prime energy source in most eukaryotic cells, but these highly dynamic organelles are also involved in a multitude of cellular events. Disruption of mitochondrial homeostasis and the subsequent mitochondrial dysfunction plays a key role in the pathophysiology of neurodegenerative diseases. Therefore, maintenance of mitochondrial integrity through different surveillance mechanisms is critical for neuronal survival. In this thesis I have studied in depth some mitochondrial quality control mechanisms in the context of PD and HD, in order to broaden the knowledge about the pathomechanisms leading to cell death. In the first chapter I have studied mitochondrial protein import in in vitro and in vivo models of PD. In vitro, complex I inhibition, a characteristic pathological hallmark in PD, impaired mitochondrial protein import. This was associated with OXPHOS protein downregulation, accumulation of aggregated proteins inside mitochondria and downregulation of mitochondrial chaperones. Therefore, we aimed to reestablish the mitochondrial protein import by overexpressing two key components of the system: translocase of the outer membrane 20 (TOM20) and translocase of the inner membrane 23 (TIM23). Overexpression of TOM20 and TIM23 in vitro restored protein import into mitochondria and ameliorated mitochondrial dysfunction and cell death. Complex I inhibition also impaired mitochondrial protein import and led to dopaminergic neurodegeneration in vivo. Overexpression of TIM23 partially rescued protein import into mitochondria and slightly protected dopaminergic neurons in the SNpc. On the contrary, TOM20 overexpression did not rescue protein import into mitochondria and exacerbated neurodegeneration in both SNpc and striatum. These results highlight mitochondrial protein import dysfunction and the distinct role of two of their components in the pathogenesis of PD and suggest the need for future studies to target other elements in the system. In the second chapter, I have studied the role of huntingtin in mitophagy and how the polyglutamine expansion present in mutant huntingtin can affect its function. For such, I worked with differentiated striatal ST-Q7 (as control) and ST-Q111 (as mutant) cells, expressing full length huntingtin. In these conditions, induced mitophagy was not mediated by Parkin recruitment into depolarized mitochondria. Mutant huntingtin impaired induced mitophagy by altering wildtype huntingtin scaffolding activity at different steps of mitophagy process: (i) ULK1 activation through its release from the mTORC1, (ii) Beclin1-Vps15 complex formation, (iii) interaction of the mitophagy adapters OPTN and NDP52 with huntingtin and (iv) with LC3. As a result, mitochondria from ST-Q111 cells exhibited increased damage and altered mitochondrial respiration. These results uncover impaired mitophagy as a potential pathological mechanism linked with HD. In conclusion, we have discovered new mitochondrial targets for PD and HD emphasizing the important role that mitochondrial quality control plays in neurodegeneration
Rodeiro, Carmen Lucia Vidal. "Some issues in disease map modelling and surveillance of diseases". Thesis, University of Aberdeen, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.415553.
Texto completo da fonteSchwengler, Franziska. "Prion Diseases". Diss., lmu, 2005. http://nbn-resolving.de/urn:nbn:de:bvb:19-36790.
Texto completo da fonteLivros sobre o assunto "Diseases"
Corporation, Springhouse, ed. Diseases. Springhouse, Pa: Springhouse Corp., 1993.
Encontre o texto completo da fonteCorporation, Springhouse, ed. Diseases. 3a ed. Springhouse, Pa: Springhouse Corp., 2001.
Encontre o texto completo da fonteH, Bunch Bryan, e Grolier Educational (Firm), eds. Diseases. Danbury, CT: Grolier Educational, 1997.
Encontre o texto completo da fonteCorporation, Springhouse, ed. Diseases. Springhouse, Pa: Springhouse Corporation, 1998.
Encontre o texto completo da fonteCorporation, Springhouse, ed. Diseases. 2a ed. Springhouse, Pa: Springhouse Corp., 1997.
Encontre o texto completo da fonteR, Nichols, ed. Mycoplasma diseases of ruminants: Disease, diagnosis and control. Wallingford: CABI, 2006.
Encontre o texto completo da fonteWerker, Paul M. N., Joseph Dias, Charles Eaton, Bert Reichert e Wolfgang Wach, eds. Dupuytren Disease and Related Diseases - The Cutting Edge. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-32199-8.
Texto completo da fonteMonette, P. L. Grape diseases: Corky bark disease and stem pitting. Toronto, Ont: Ministry of Agriculture and Food, 1993.
Encontre o texto completo da fonteJay, Bernstein, e Glassock Richard J, eds. Renal disease: Classification and atlas of glomerular diseases. 2a ed. New York: Igaku-Shoin, 1995.
Encontre o texto completo da fonteNeighbors, Marianne. Human diseases. 2a ed. Clifton Park, NY: Delmar Learning, 2005.
Encontre o texto completo da fonteCapítulos de livros sobre o assunto "Diseases"
Weis, Serge, Michael Sonnberger, Andreas Dunzinger, Eva Voglmayr, Martin Aichholzer, Raimund Kleiser e Peter Strasser. "Neurodegenerative Diseases: Parkinson Disease". In Imaging Brain Diseases, 1001–20. Vienna: Springer Vienna, 2019. http://dx.doi.org/10.1007/978-3-7091-1544-2_37.
Texto completo da fonteWeis, Serge, Michael Sonnberger, Andreas Dunzinger, Eva Voglmayr, Martin Aichholzer, Raimund Kleiser e Peter Strasser. "Neurodegenerative Diseases: Huntington Disease". In Imaging Brain Diseases, 1059–68. Vienna: Springer Vienna, 2019. http://dx.doi.org/10.1007/978-3-7091-1544-2_40.
Texto completo da fonteGregori, Maria, e Francesca Re. "Neurodegenerative Diseases - Alzheimer's Disease". In Pharmaceutical Nanotechnology: Innovation and Production, 649–60. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2016. http://dx.doi.org/10.1002/9783527800681.ch27.
Texto completo da fonteTamma, Filippo. "Extrapyramidal Diseases: Parkinson’s Disease". In Prognosis of Neurological Diseases, 363–68. Milano: Springer Milan, 2015. http://dx.doi.org/10.1007/978-88-470-5755-5_28.
Texto completo da fonteValzania, Franco. "Extrapyramidal Diseases: Huntington’s Disease". In Prognosis of Neurological Diseases, 375–79. Milano: Springer Milan, 2015. http://dx.doi.org/10.1007/978-88-470-5755-5_30.
Texto completo da fonteKenanidis, Eustathios, Andreas Leonidou, Michael Potoupnis, Eleftherios Tsiridis, Aristotelis Kourtis e Richard P. Baker. "Neurologic Diseases: Parkinson’s Disease". In The Adult Hip - Master Case Series and Techniques, 327–37. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-64177-5_11.
Texto completo da fonteMuñoz, Melissa, Elizabeth Cieniewicz e James E. Faust. "Diseases and disease management." In Cut flowers and foliages, 258–315. Wallingford: CABI, 2021. http://dx.doi.org/10.1079/9781789247602.0006.
Texto completo da fonteWeis, Serge, Michael Sonnberger, Andreas Dunzinger, Eva Voglmayr, Martin Aichholzer, Raimund Kleiser e Peter Strasser. "Neurodegenerative Diseases: Alzheimer Disease (AD)". In Imaging Brain Diseases, 897–931. Vienna: Springer Vienna, 2019. http://dx.doi.org/10.1007/978-3-7091-1544-2_32.
Texto completo da fonteMisra, Ashok K. "Diseases." In Guava: botany, production and uses, 285–328. Wallingford: CABI, 2021. http://dx.doi.org/10.1079/9781789247022.0015.
Texto completo da fonteKanki, Phyllis J. "Infectious Diseases infectious disease , Introduction". In Encyclopedia of Sustainability Science and Technology, 5378–82. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-0851-3_927.
Texto completo da fonteTrabalhos de conferências sobre o assunto "Diseases"
Olshevskaya, A. V., M. Yu Gapon, N. V. Gapon, M. M. Zhdanova, A. T. Rybak, A. V. Vershinina, S. A. Marchenko, A. E. Аzhinov e D. V. Rudoy. "RECOGNITION OF THE STATE OF CROPS USING NEURAL NETWORK MONITORING TOOLS". In STATE AND DEVELOPMENT PROSPECTS OF AGRIBUSINESS. ООО «ДГТУ-Принт» Адрес полиграфического предприятия: 344003, г. Ростов-на-Дону, пл. Гагарина,1., 2024. http://dx.doi.org/10.23947/interagro.2024.115-118.
Texto completo da fonteArantes, Ellen Carla Gonçalves, Mateus Emanuel Segalla Ribeiro, Maria Clara Diniz Martins, Kamilla Caetano Costa Lemos e Josy Barros Noleto de Souza. "Neglected diseases". In IV Seven International Congress of Health. Seven Congress, 2024. http://dx.doi.org/10.56238/homeivsevenhealth-027.
Texto completo da fonteHELIALDO SOUSA DE OLIVEIRA FILHO, FRANCISCO, PRISCILA DOURADO EVANGELISTA, PRISCILA GARCIA CÂMARA CABRAL TAVARES, LUIZ VALÉRIO COSTA VASCONCELOS, MARINA PINTO ROCHA, ANA CAROLINA CAVALCANTE MENDONÇA, ADAH SOPHIA RODRIGUES VIEIRA et al. "LEPROSY: INFECTIOUS DISEASE MIMICKING RHEUMATIC DISEASES". In SBR 2021 Congresso Brasileiro de Reumatologia. Sociedade Brasileiro de Reumatologia, 2021. http://dx.doi.org/10.47660/cbr.2021.1806.
Texto completo da fonteGómez, Carlota, Irene Jimeno, Leonardo De la Torre e Monika Wozniak. "VISIBILIZING INVISIBLE DISEASES: FACE CHAGAS DISEASE". In 11th International Conference on Education and New Learning Technologies. IATED, 2019. http://dx.doi.org/10.21125/edulearn.2019.0932.
Texto completo da fonteMesihović-Dinarević, Senka, Mirza Halimić e Almira Kadić. "ACQUIRED AND GENETICALLY PREDISPOSED HEART DISEASE IN CHILDREN". In Acquired Heart Diseases. Academy of Sciences and Arts of Bosnia and Herzegovina, 2015. http://dx.doi.org/10.5644/pi2015-158-01.
Texto completo da fonteOmerčahić-Dizdarević, Aida, Velma Selmanović e Adisa Čengić. "RHEUMATIC FEVER: A DISEASE THAT SHOULD NOT YET BE FORGOTTEN". In Acquired Heart Diseases. Academy of Sciences and Arts of Bosnia and Herzegovina, 2015. http://dx.doi.org/10.5644/pi2015-158-02.
Texto completo da fonteBegić, Fatima. "ACQUIRED VALVULAR HEART DISEASE IN CHILDREN: OUR EXAMPLES". In Acquired Heart Diseases. Academy of Sciences and Arts of Bosnia and Herzegovina, 2015. http://dx.doi.org/10.5644/pi2015-158-03.
Texto completo da fonteCerić, Šejla, e Elma Kučukalić-Selimović. "THE IMPORTANCE OF PHARMACOLOGICAL STRESS IN MYOCARDIAL PERFUSION SCINTIGRAPHY". In Acquired Heart Diseases. Academy of Sciences and Arts of Bosnia and Herzegovina, 2015. http://dx.doi.org/10.5644/pi2015-158-04.
Texto completo da fonteKušljugić, Zumreta, e Katarina Kovačević. "BRUCELLA ENDOCARDITIS: A CASE STUDY". In Acquired Heart Diseases. Academy of Sciences and Arts of Bosnia and Herzegovina, 2015. http://dx.doi.org/10.5644/pi2015-158-05.
Texto completo da fonteKulić, Mehmed, Ibrahim Terzić, Mirza Dilić, Elnur Tahirović e Muhamed Spužić. "PRIMARY PERCUTANEOUS CORONARY INTERVENTIONS NETWORK IN BOSNIA AND HERZEGOVINA". In Acquired Heart Diseases. Academy of Sciences and Arts of Bosnia and Herzegovina, 2015. http://dx.doi.org/10.5644/pi2015-158-06.
Texto completo da fonteRelatórios de organizações sobre o assunto "Diseases"
Ogden, N. H., C. Bouchard, G. Brankston, E. M. Brown, T. Corrin, A. Dibernardo, M A Drebot et al. Infectious diseases. Natural Resources Canada/CMSS/Information Management, 2022. http://dx.doi.org/10.4095/329532.
Texto completo da fonteVlasova, Liubov, Olesya Musina, Lidia Timeeva e Irina Yarunina. Occupational Diseases. SIB-Expertise, julho de 2022. http://dx.doi.org/10.12731/er0597.29072022.
Texto completo da fonteWise, Kiersten, Carl Bradley, Loren Giesler, Bill Johnson, Travis Legleiter, Mark Licht, Daren Mueller et al. Soybean Seedling Diseases. United States: Crop Protection Netework, junho de 2015. http://dx.doi.org/10.31274/cpn-20190620-023.
Texto completo da fonteLyons, Suzannah. Targeting infectious diseases. Monash University, fevereiro de 2024. http://dx.doi.org/10.54377/7615-dbfa.
Texto completo da fonteZhao, Junyu, Yutian Tian, Haipeng Wang, Jinming Yao, Wang Song e Yaru Mou. Thyroid diseases are associated with coronavirus disease 2019 (COVID-19) infection. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, setembro de 2021. http://dx.doi.org/10.37766/inplasy2021.9.0079.
Texto completo da fonteBarros-Poblete, Marisol, Rodrigo Torres-Castro, Mauricio Henríquez, Anita Guequen, Isabel Blanco e Carlos Flores. Dysbiosis as a prognostic factor for clinical worsening in chronic respiratory disease: A systematic review and metanalysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, abril de 2022. http://dx.doi.org/10.37766/inplasy2022.4.0089.
Texto completo da fonteFreeman, Stanley, e Daniel Legard. Epidemiology and Etiology of Colletotrichum Species Causing Strawberry Diseases. United States Department of Agriculture, setembro de 2001. http://dx.doi.org/10.32747/2001.7695845.bard.
Texto completo da fonteWestergaard, Jørgen M. Wildlife and Infectious Animal Diseases. Nordic Council of Ministers, março de 2014. http://dx.doi.org/10.6027/tn2014-508.
Texto completo da fonteM. Westergaard, Jørgen. Contingency Planning for Animal Diseases. Nordic Council of Ministers, março de 2014. http://dx.doi.org/10.6027/tn2014-509.
Texto completo da fonteTignor, Gregory H. Drug Development against Viral Diseases. Fort Belvoir, VA: Defense Technical Information Center, fevereiro de 1987. http://dx.doi.org/10.21236/ada201949.
Texto completo da fonte